4.6 Article

IL-10 as a Th2 Cytokine: Differences Between Mice and Humans

Journal

JOURNAL OF IMMUNOLOGY
Volume 207, Issue 9, Pages 2205-2215

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.2100565

Keywords

-

Categories

Funding

  1. American Heart Association [18TPA34170206]
  2. Department of Health and Human Services/National Institutes of Health [5R21AI142281]
  3. University of Nebraska-Lincoln Institutional funds

Ask authors/readers for more resources

The discovery of IL-10 over 30 years ago marked the beginning of our understanding of how cytokines regulate immune responses. IL-10 has anti-inflammatory action by suppressing APCs, which indirectly inhibits Th1 cells. Regulatory T cells also play a role in IL-10-mediated suppression.
The discovery of IL-10 more than 30 years ago marked the beginning of our understanding of how cytokines regulate immune responses, based on cross-regulation between Th1 and Th2 cytokines. Although multiple cell types were shown to produce IL-10, its identity as a Th2 cytokine remained strong because it was rigidly associated with Th2 clones in mice, whereas both Th1 and Th2 clones could secrete IL-10 in humans. However, as new Th1/Th2 cell functionalities emerged, antiinflammatory action of IL-10 gained more attention than its inhibitory effect on Th1 cells, which may occur as an indirect consequence of suppression of APCs. This notion is also supported by the discovery of regulatory T cells, whose suppressor functions involve the mediation of IL-10, among other molecules. From this perspective, we discuss the functionalities of IL-10 by highlighting important differences between mice and humans with an emphasis on the Th1 and Th2 paradigm.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Multidisciplinary Sciences

Attenuated strain of CVB3 with a mutation in the CAR-interacting region protects against both myocarditis and pancreatitis

Ninaad Lasrado, Arunakumar Gangaplara, Chandirasegaran Massilamany, Rajkumar Arumugam, Allison Shelbourn, Mahima T. Rasquinha, Rakesh H. Basavalingappa, Gustavo Delhon, Shi-Hua Xiang, Asit K. Pattnaik, David Steffen, Jay Reddy

Summary: The study developed a live attenuated vaccine against Coxsackievirus B3, which prevented myocarditis and pancreatitis in mice by inducing virus-neutralizing antibodies and antigen-specific T cell responses, providing a potential candidate for vaccine studies.

SCIENTIFIC REPORTS (2021)

Article Microbiology

Mt10-CVB3 Vaccine Virus Protects against CVB4 Infection by Inducing Cross-Reactive, Antigen-Specific Immune Responses

Ninaad Lasrado, Rajkumar Arumugam, Mahima T. Rasquinha, Meghna Sur, David Steffen, Jay Reddy

Summary: The study demonstrated that the Mt10 vaccine can induce cross-protection against multiple CVB serotypes, including the ability to generate cross-reactive neutralizing antibodies for CVB1 and CVB4. The vaccine showed 92% efficacy in preventing myocarditis and pancreatitis caused by CVB4, with cross-reactive neutralizing antibodies against CVB1, CVB3, and CVB4 persisting in the animals. Evaluation of antigen-specific immune responses indicated the production of viral protein 1 (VP1)-reactive antibodies and VP1-specific CD4 T cells capable of producing multiple T cell cytokines. Furthermore, no viral nucleic acid was found in the heart or pancreas of vaccinated animals challenged with CVB4, suggesting the potential of the Mt10 vaccine for preventing heart and pancreatic diseases caused by enteroviruses.

MICROORGANISMS (2021)

Article Multidisciplinary Sciences

Dissecting the cellular landscape and transcriptome network in viral myocarditis by single-cell RNA sequencing

Ninaad Lasrado, Nicholas Borcherding, Rajkumar Arumugam, Timothy K. Starr, Jay Reddy

Summary: Coxsackievirus B3-induced myocarditis is commonly studied in mice to understand viral pathogenesis. Single-cell RNA sequencing of heart cells revealed the involvement of myeloid cells, T cells, and fibroblasts in the disease. Communication networks and signaling pathways play a crucial role in regulating the cardiac cellular response.

ISCIENCE (2022)

Article Biology

PhIP-Seq Reveals Autoantibodies for Ubiquitously Expressed Antigens in Viral Myocarditis

Mahima T. Rasquinha, Ninaad Lasrado, Erika Petro-Turnquist, Eric Weaver, Thiagarajan Venkataraman, Daniel Anderson, Uri Laserson, H. Benjamin Larman, Jay Reddy

Summary: In this study, the researchers analyzed the production of heart antigen antibodies in a mouse model of CVB3 myocarditis using the PhIP-Seq technique. They identified several previously unreported protein antibodies that may be relevant to human disease.

BIOLOGY-BASEL (2022)

Article Immunology

A Monovalent Mt10-CVB3 Vaccine Prevents CVB4-Accelerated Type 1 Diabetes in NOD Mice

Mahima T. Rasquinha, Ninaad Lasrado, Meghna Sur, Kiruthiga Mone, Haowen Qiu, Jean-Jack Riethoven, Raymond A. Sobel, Jay Reddy

Summary: In this study, a live-attenuated CVB3 vaccine virus called Mt10 was developed, which protected genetically predisposed NOD mice from CVB4-triggered type 1 diabetes but did not alter the subsequent development of spontaneous diabetes. The vaccine induced significant levels of neutralizing antibodies, mainly of the IgG2c isotype, and the virus was not detected in vaccinated animals. Monitoring blood glucose levels and insulin antibodies helped predict vaccine responses.

VACCINES (2023)

Review Immunology

Vaccines against Group B Coxsackieviruses and Their Importance

Kiruthiga Mone, Ninaad Lasrado, Meghna Sur, Jay Reddy

Summary: In this review, the attributes of experimentally tested vaccines have been analyzed, and their merits, demerits or limitations, as well as their impact in preventing infections, especially myocarditis and type 1 diabetes, have been discussed.

VACCINES (2023)

No Data Available